’˜‘E‘ΰ 



άˆδ —C‰ξ
ΰh‰ίŽθpEƒ`ƒ…[ƒuƒVƒƒƒ“ƒgp‚̍ŐVŽ–ξ
“ϊ–{‚ΜŠα‰Θ@‘ζ94Šͺ‘ζ8†@Page 1080-1084 (2023.8) “ϊ–{Šα‰Θˆγ‰ο


¬X@—Α•½Aˆξ’J@‘ε
–Ϊ‚Ε‚έ‚ιƒVƒŠ[ƒY@‘ζ21‰ρ@ƒwƒ‚ƒOƒƒrƒ“ƒrƒfƒIƒCƒ[ƒWƒ“ƒO‚Ε–[…Γ–¬‚πf‚ι
Frontiers in Glaucoma2023 ‘ζ66†@P1-5i2023.8j ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽΠ@‘εγ


Šβ핁@Œ’‘Ύ˜Y
BG101-350 ŒŒŠΗVΆ—Ξ“ΰαA‰‰ρ—Ξ“ΰαŽθp
—Ξ“ΰαƒƒ“ƒOƒ`ƒ…[ƒuƒVƒƒƒ“ƒgŽθpŽΐ‘Hƒ}ƒjƒ…ƒAƒ‹(2023.9)@“ϊ–{ˆγŽ–V•ρŽΠ@“Œ‹ž


Ό‘Ί@Œ’‘ε
ŽΚ^ƒZƒ~ƒi[@Š΄υ«Šp–Œ‰ŠŽ‘—Γ‘OŒγ‚ΜŠp–ŒŒ`σ•Ο‰»
‚ ‚½‚η‚΅‚’Šα‰Θ@‘ζ40Šͺ9†p.1195-1196i2023.9j@ƒƒfƒBƒJƒ‹ˆ¨o”Ł@“Œ‹ž


Šβ핁@Œ’‘Ύ˜YAˆξ’J@‘ε
yRVEGF—Γ–@‚πƒ}ƒXƒ^[‚·‚ι!zŒŒŠΗVΆ—Ξ“ΰα‚Ι‘Ξ‚·‚ιRVEGF—Γ–@@Ž„‚ΜŽ‘—Ðν—ͺ(‰πΰ)
OCULISTA(2187-5855)127† Page58-63(2023.10)@‘S“ϊ–{•a‰@o”Ε‰ο@“Œ‹ž


·‰ͺ@³˜a
yƒƒCƒ““ΑWzŠO—ˆ‚ΕŒ©“¦‚΅‚Δ‚Ν‚’‚―‚Θ‚’ŽΎŠ³11`f’fEŽ‘—Γ‚Μƒ|ƒCƒ“ƒg‚π‰Ÿ‚³‚¦‚ι`
6Ν@“œ”A•a–Τ–ŒΗ‚πŒ©“¦‚·‚ȁI
Šα‰ΘƒOƒ‰ƒtƒBƒbƒN@12Šͺ5† p513-518@(2023.10)ƒƒfƒBƒJo”Ł@‘εγ


ˆξ’J@‘ε
Šͺ“ͺŒΎ@“ΑW@ˆΣŠO‚Ζ’m‚η‚Θ‚’¬Ž™‚ΜŽ‹—Ν’α‰Ί
—Տ°Šα‰Θ 77Šͺ12† Page1389 (2023.11)@ˆγŠw‘‰@@“Œ‹ž


™Œ΄@—F‰ΐ
yˆΣŠO‚Ζ’m‚η‚Θ‚’¬Ž™‚ΜŽ‹—Ν’α‰Ίz‘SgŽΎŠ³‚π”Ί‚€¬Ž™‚ΜŽ‹—Ν’α‰Ί(‰πΰ)
—Տ°Šα‰Θ(0370-5579)77Šͺ12† Page1473-1478(2023.11)@ˆγŠw‘‰@@“Œ‹ž


Œγ‘ς@½A‚‘Ί@‰ΐO
Clinical Challenge@—τEŒ΄«–Τ–Œ”—£‚Ι‘Ξ‚·‚ιΙŽq‘ΜŽθpŒγ‚Μ‘ΜˆΚ§Œΐ‚Ι‚Β‚’‚ččl‚·‚ι(‰πΰ)
—Տ°Šα‰Θ(0370-5579)77Šͺ12† Page1378-1382(2023.11)@ˆγŠw‘‰@@“Œ‹ž


Ό‘Ί@Œ’‘ε
Clinical Challenge Šp–Œ¬‘χ‚Ι‚ζ‚ιŽ‹—Ν’α‰Ί‚π‚«‚½‚΅‚½1—α
—Տ°Šα‰Θ(0370-5579)77Šͺ13†@Page1521-1523 (2023.12)@ˆγŠw‘‰@@“Œ‹ž


Ό‘Ί@Œ’‘ε
‘ζ77‰ρ“ϊ–{—Տ°Šα‰ΘŠw‰οƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[u–’—ˆ‚Ι‚Β‚Θ‚ͺ‚ιI‚Β‚Θ‚°‚ιISeason3`‹P‚―Iƒ_ƒCƒo[ƒVƒeƒB`vˆσΫ‹L
“ϊ–{‚ΜŠα‰Θ@‘ζ95Šͺ‘ζ1†@Page 68-69 (2024.1) “ϊ–{Šα‰Θˆγ‰ο


Šβ핁@Œ’‘Ύ˜YAˆξ’J@‘ε
‰ζ‘œ‚ΕŒ©‚ι—Ξ“ΰα‚Μ•a‘ԁ@MRI‚Ε‚έ‚ιƒoƒ‹ƒxƒ‹ƒg—Ξ“ΰαƒCƒ“ƒvƒ‰ƒ“ƒgŽθpŒγ‚Μΰh‰ί–E
Frontiers in Glaucoma ‘ζ67†Page1-4i2024.2jƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽΠ@“Œ‹ž



 

‰ί‹Ž‚̋ƐΡ

’˜‘E‘ΰ@2022
’˜‘E‘ΰ@2021
’˜‘E‘ΰ@2020
’˜‘E‘ΰ@2019
’˜‘E‘ΰ@2018
’˜‘E‘ΰ@2017
’˜‘E‘ΰ@2016
’˜‘E‘ΰ@2015
’˜‘E‘ΰ@2014
’˜‘E‘ΰ@2013
’˜‘E‘ΰ@2012